Achillion Presents at Wells Fargo 2013 Healthcare Conference

Achillion, an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease, announced in a news release that Milind Deshpande, President and CEO of Achillion, and members of the senior management team, will present a corporate update and participate on a HCV Panel at the Wells Fargo 2013 Healthcare Conference on June 18 in Boston, MA.  Achillion archives live audio broadcasts and webcasts of Company presentations on the Company’s website, http://www.achillion.com, under the “News Center” section.